Optic neuropathy after chimeric antigen receptor T-cell therapy
J Formos Med Assoc
.
2022 May;121(5):1012-1013.
doi: 10.1016/j.jfma.2021.10.020.
Epub 2021 Nov 6.
Authors
Ching-Wen Huang
1
,
Cheng-Hong Tsai
2
,
Chao-Wen Lin
3
Affiliations
1
Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan.
2
Department of Hematology, National Taiwan University Hospital, Taipei, Taiwan.
3
Department of Ophthalmology, National Taiwan University Hospital, Taipei, Taiwan. Electronic address: wesley.lin1@gmail.com.
PMID:
34753628
DOI:
10.1016/j.jfma.2021.10.020
No abstract available
Publication types
Letter
MeSH terms
Cell- and Tissue-Based Therapy
Humans
Optic Nerve
Optic Nerve Diseases* / etiology
Optic Nerve Diseases* / therapy
Receptors, Chimeric Antigen*
Substances
Receptors, Chimeric Antigen